Drugs for attention deficit-hyperactivity disorder do not increase the mid-term risk of sudden death in children: A meta-analysis of observational studies

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4320-4321

  Mazza, Marianna ^a   D'Ascenzo, Fabrizio ^b,c   Davico, Chiara ^b   Biondi Zoccai, Giuseppe ^c,d   Frati, Giacomo ^d,e   Romagnoli, Enrico ^f   Bassi, Bianca ^b   Janiri, Luigi ^a   Moretti, Claudio ^b   Gaita, Fiorenzo ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Meta analysis and Evidence based Medicine Training in Cardiology (METCARDIO)   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e IRCCS NEUROMED   (Italy)

^f Division of Cardiology   (Italy)

Author keywords

Attention deficit hyperactivity disorder; Cardiovascular disease; Meta analysis

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHILD; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HEART DISEASE; HIGH RISK PATIENT; HUMAN; LETTER; OBSERVATIONAL STUDY; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; SUDDEN DEATH; SURVIVAL TIME; SYSTEMATIC REVIEW;

ATTENTION DEFICIT-HYPERACTIVITY DISORDER; CARDIOVASCULAR DISEASE; META-ANALYSIS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEATH, SUDDEN; HUMANS; OBSERVATIONAL STUDY AS TOPIC; RISK FACTORS;

EID: 84886245729     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.04.169     Document Type: Article

References (8)

1. B. Vitiello Understanding the risk of using medications for ADHD with respect to physical growth and cardiovascular function Child Adolesc Psychiatr Clin N Am 17 2008 459 471
2. R. Donner, M.A. Michaels, and P.J. Ambrosini Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder Biol Psychiatry 61 2007 706 712
3. H. Schelleman, W. Bilker, and B.L. Strom Cardiovascular events and death in children exposed and unexposed to ADHD agents Pediatrics 127 2011 1102 1110
4. L.A. Habel, W.O. Cooper, and C.M. Sox ADHD medications and risk of serious cardiovascular events in young and middle-aged adults JAMA 306 2011 2673 2683
5. W.O. Cooper, L.A. Habel, and C.M. Sox ADHD drugs and serious cardiovascular events in children and young adults N Engl J Med 365 2011 1896 1904
6. C.L. Barry, A. Martin, and S.H. Busch ADHD medication use following FDA risk warnings J Ment Health Policy Econ 15 2012 119 125
7. N.D. Volkow, G.J. Wang, and Fowler Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma Psychopharmacology 166 2003 264 270
8. H.A. Spiller, C.P. Lintner, and M.L. Winter Atomoxetine ingestions in children: a report from poison centers Ann Pharmacother 39 2005 1045 1048